tiprankstipranks
Trending News
More News >
Iovance Biotherapeutics (DE:2LB)
NASDAQ:2LB

Iovance Biotherapeutics (2LB) Revenue

Compare
17 Followers

Iovance Biotherapeutics Revenue

Iovance Biotherapeutics had a revenue of 86.77M in the quarter ending Dec 31, 2025, with 28.64%. This bring the company's revenue in the last twelve months to 263.50M, Decreased 5.22%. In the fiscal year ending Dec 31, 2025, Iovance Biotherapeutics had annual revenue of 263.50M with 60.60% growth.
Revenue (ttm)
263.50M
Revenue Growth
P/S Ratio
5.04
Revenue/Employee
€314,442
Employees
838
Market Cap
€1.33B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
263.50M99.43M+60.60%
Dec 31, 2024
164.07M162.88M+13,698.99%
Dec 31, 2023
1.19M+∞%
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017